HF
HSTO

HRT Financial’s Histogen Inc. Common Stock HSTO Stock Holding History

HRT Financial’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11,356
Closed -$26K – 3896
2022
Q2 		$26K Buy
+11,356
New +$40.8K ﹤0.01% 2577
2019
Q3 		– Sell
-88
Closed -$4K – 1672
2019
Q2 		$4K Buy
+88
New +$15.3K ﹤0.01% 726

Other funds holding HSTO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HRT Financial's HSTO Position: Q3 2022 in Review

HRT Financial sold out of Histogen Inc. Common Stock (HSTO) in Q3 2022, closing a stake of 11,356 shares — an estimated $26K sold.

HRT Financial first reported a position in HSTO in Q2 2019 and held it in 2 quarters. The position peaked at $26K in Q2 2022. 13 funds tracked by Wall St. Rank hold HSTO as of Q3 2022.

  • HRT Financial reported no remaining Histogen Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • HRT Financial sold 11,356 Histogen Inc. Common Stock shares in Q3 2022, an estimated $26K.
  • HRT Financial first reported a position in Histogen Inc. Common Stock in Q2 2019 and held it in 2 quarters.
  • HRT Financial's Histogen Inc. Common Stock position peaked at $26K in Q2 2022.
  • 13 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2022.

Based on HRT Financial's 13F filing for Q3 2022, filed 14 Nov 2022.